Occluding Mucous Airway Plugs in Patients with Obstructive Lung Diseases: a New Treatable Trait?
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
https://bit.ly/4gyJHFW.
References
1.
Zheng J, Wen F, Bai C, Wan H, Kang J, Chen P
. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2014; 2(3):187-94.
DOI: 10.1016/S2213-2600(13)70286-8.
View
2.
Chalmers J, Polverino E, Crichton M, Ringshausen F, Soyza A, Vendrell M
. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023; 11(7):637-649.
DOI: 10.1016/S2213-2600(23)00093-0.
View
3.
Shah B, Singh B, Wang Y, Xie S, Wang C
. Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment. Mediators Inflamm. 2023; 2023:8840594.
PMC: 10344637.
DOI: 10.1155/2023/8840594.
View
4.
Centeio R, Ousingsawat J, Schreiber R, Kunzelmann K
. CLCA1 Regulates Airway Mucus Production and Ion Secretion Through TMEM16A. Int J Mol Sci. 2021; 22(10).
PMC: 8151571.
DOI: 10.3390/ijms22105133.
View
5.
Martinez-Garcia M, Faner R, Oscullo G, Rosa-Carrillo D, Soler-Cataluna J, Ballester M
. Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long-term observational study. Respirology. 2021; 26(8):776-785.
DOI: 10.1111/resp.14086.
View